Data Manipulation Not Common, But Happens "More Than I Would Have Expected," US FDA's Sharpless Says

 
• By Michael Cipriano
  
FDA acting Commissioner Ned Sharpless speaking at FDLI 2019
Norman Sharpless broadly addressed the frequency of data manipulation at the US FDA.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet